[Author]
[Institution]
Research critique on Pre-hospital treatment of Opioid overdose in Copenhagen The obsession of opioid overdose has become extensive these days throughout the world (Clarke et al, 2005, p. 616) . The use of narcotics has led human lives towards dreadful circumstances and it has been unveiled that the increase in death rates of opioid users is due to the immense ingestion of narcotics (Sporer & Kral, 2007, p. 177). Numerous research studies have disclosed that Copenhagen, the capital of Denmark has a majority of opioid overdose users (Vilke et al, 1999, p. 186; Pedersen et al, 1997, p. 95; Lenton & Hargreaves, 2000, p. 263) . The article “Pre hospital treatment of opioid overdose in Copenhagen—Is it safe to discharge on scene?” written by S.S Rudolph, G.Jehu, K.Nielsen & L.S. Rasmussen critically examines the situation of opioid overdose patients in Copenhagen. It describes that results obtained after the on scene release of such patients. The article precisely discusses the opioid overdose cases occurred during 1994-2003 and inspects the core reasons behind the death of certain patients. Opiod overdose effects are outrageous and it has the capability to escort towards horrible circumstances. Naloxone is the most efficient and effective treatment dose for the patients suffering from these conditions. The Medical Emergency Care Unit (MECU) is the primary source for the treatment of opiod overdose (Wanger et al, 1998, p. 299; Kerr et al, 2008, p. 379). The team is available 24hours and provides medication facilities to the affected ones. The intention of this medication service is to cure the patients on spot and release them on scene after treatment (Rudolph, Nielsen & Rasmussen, 2011).
Purpose of the Study
The purpose of the study described in the article is to examine the radical impacts of Opioid overdose prevalent
References: Ashton, H., & Hassan, Z. 2006. “Intranasal naloxone in suspected opioid overdose”. Emergency Medicine Journal, 23(3), pp. 221-223. Baca, C. T., & Grant, K. J. 2005. “Take‐home naloxone to reduce heroin death”, Addiction, 100(12), pp. 1823-1831 Boyd, J Clarke, S. F., Dargan, P. I., & Jones, A. L. 2005. “Naloxone in opioid poisoning: walking the tightrope”. Emergency Medicine Journal, 22(9), 612-616 Heyerdahl, F., Hovda, K Lenton, S. R., & Hargreaves, K. M. 2000. “Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?” Medical Journal of Australia, 173(5), 260-263. Okie, S. 2010. “A flood of opioids, a rising tide of deaths”, New England Journal of Medicine, 363(21), 1981-1985. Pedersen, C. B., Steentoft, A., Worm, K., Sprehn, M., Mogensen, T., & Sørensen, M. B. 1997. “Prehospital Treatment of Patients with IV Heroin Overdose: What Are We Treating?” Prehospital and Disaster Medicine, 12(02), 92-95. Robertson, T. M., Hendey, G. W., Stroh, G., & Shalit, M. 2009. “Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose”. Prehospital Emergency Care, 13(4), 512-515. Rudolph, S. S., Jehu, G., Nielsen, S. L., Nielsen, K., Siersma, V., & Rasmussen, L. S. 2011. “Prehospital treatment of opioid overdose in Copenhagen—Is it safe to discharge on-scene? Resuscitation, 82(11), 1414-1418. Sporer, K. A., 1999. “Acute heroin overdose”, Ann Intern Med, 130(7), 584-590. Sporer, K. A., & Kral, A. H., 2007. “Prescription naloxone: a novel approach to heroin overdose prevention”. Annals of emergency medicine 49(2), 172-177. Sporer, K. A., Firestone, J., & Isaacs, S. M., 2008. “Out‐of‐hospital Treatment of Opioid Overdoses in an Urban Setting”. Academic Emergency Medicine, 3(7), 660-667. Vilke, G. M., Buchanan, J., Dunford, J. V., & Chan, T. C. 1999. “Are heroin overdose deaths related to patient release after pre hospital treatment with naloxone?” Pre hospital Emergency Care, 3(3), 183-186. Wanger, K., Brough, L., Macmillan, I., Goulding, J., MacPhail, I., & Christenson, J. M., 1998. “Intravenous vs Subcutaneous Naloxone for Out‐of‐hospital Management of Presumed Opioid Overdose”. Academic emergency medicine 5(4), 293-299.